Search Articles — Sudonull

Search Results

In this project

Loot boxes for children: restrictions in Russia

https://sudonull.com/loot-boxes-for-children-restrictions-in-russia

Deputy Milonov proposed restricting loot boxes for minors. We analyze the essence of the initiative, international experience, and possible consequences for the gaming industry.

From other projects

Impact of Plant-Based Diets on Children's Health: Analysis of 59 Studies

https://ymaho.com/impact-of-plant-based-diets-on-children-s-health-analysis-of-59-studies

A meta-analysis of 59 studies showed that veganism and vegetarianism are safe for children when controlling for deficiencies of B12, iron, and calcium. Learn about the risks and benefits of plant-based nutrition.

Repeated COVID in children: risk of long COVID twice as high

https://ymaho.com/repeated-covid-in-children-risk-of-long-covid-twice-as-high

Repeated COVID-19 in children increases the risk of long COVID by 2 times: myocarditis, thrombosis, cognitive impairment. Learn about the risks and protect your child.

Malaria vaccine R21 approved by WHO: 75% efficacy

https://ymaho.com/malaria-vaccine-r21-approved-by-who-75-efficacy

WHO approved second malaria vaccine R21/Matrix-M with 75% efficacy. Learn about benefits, price, and impact on children's health in Africa. Read more in the article.

EMA accepted the application for Dovato for children with HIV

https://ymaho.com/ema-accepted-the-application-for-dovato-for-children-with-hiv

EMA validated the application for the use of Dovato in children from 3 months with HIV. Learn how this will change pediatric therapy and strengthen ViiV's position. Read the detailed analysis.

Tzield approved for children from 1 year: delaying type 1 diabetes

https://ymaho.com/tzield-approved-for-children-from-1-year-delaying-type-1-diabetes

FDA expanded indications for teplizumab to children from one year. First drug capable of delaying diabetes for years at the preclinical stage. Learn how infusions change the prognosis for infants.

Teplizumab approved for children: delaying type 1 diabetes

https://ymaho.com/teplizumab-approved-for-children-delaying-type-1-diabetes

FDA approved teplizumab for children from 1 year old. Learn how disease-modifying therapy changes the treatment paradigm for type 1 diabetes. Detailed analysis.

FDA to Review Inhaled Insulin Afrezza for Children

https://ymaho.com/fda-to-review-inhaled-insulin-afrezza-for-children

On May 29, FDA will decide on needle-free insulin Afrezza for children aged 4–17. Learn why this is a paradigm shift in diabetology. Detailed analysis in the article.

FDA approved first gene therapy for LAD-I in children

https://ymaho.com/fda-approved-first-gene-therapy-for-lad-i-in-children

FDA approved Kresladi (marnetegragene autotemcel) — the first stem cell gene therapy for children with severe LAD-I. Learn about the mechanism, precedents, and business model. Detailed analysis on the website.

FDA to Review Afrezza: First Needle-Free Insulin for Children

https://ymaho.com/fda-to-review-afrezza-first-needle-free-insulin-for-children

On May 29, 2026, the FDA will decide on Afrezza inhaled insulin for children aged 4–17. Learn why this is a market shift and a chance for a needle-free life. Read the analysis.

Trending Now